| __timestamp | Galapagos NV | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 855506000 |
| Thursday, January 1, 2015 | 129714000 | 996170000 |
| Friday, January 1, 2016 | 139574000 | 1047690000 |
| Sunday, January 1, 2017 | 218502000 | 1324625000 |
| Monday, January 1, 2018 | 322876000 | 1416476000 |
| Tuesday, January 1, 2019 | 427320000 | 1754540000 |
| Wednesday, January 1, 2020 | 523667000 | 1829537000 |
| Friday, January 1, 2021 | 491707000 | 3051100000 |
| Saturday, January 1, 2022 | 515083000 | 2540300000 |
| Sunday, January 1, 2023 | 241294000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Data in motion
In the competitive world of biotechnology, innovation is key. Vertex Pharmaceuticals and Galapagos NV are two giants in this field, each with a unique approach to research and development (R&D). Over the past decade, Vertex has consistently outpaced Galapagos in R&D spending, investing nearly six times more on average. From 2014 to 2023, Vertex's R&D expenses grew by approximately 270%, peaking in 2023 with a staggering $3.16 billion. In contrast, Galapagos saw a more modest increase of around 117% over the same period, with its highest expenditure reaching $524 million in 2020. This significant difference highlights Vertex's aggressive strategy to maintain its leadership in innovation. As the biotech landscape evolves, these investments could be pivotal in determining which company leads the next wave of medical breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Galapagos NV
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Vertex Pharmaceuticals Incorporated
Amgen Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Galapagos NV
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Agios Pharmaceuticals, Inc. and Galapagos NV
MannKind Corporation vs Galapagos NV: Strategic Focus on R&D Spending